TY - JOUR T1 - Antiseptic-Mediated Colloid Labeling as a Potential Source of Abnormal Liver and Spleen Uptake with 99mTc-Dimercaptosuccinic Acid JF - Journal of Nuclear Medicine Technology JO - J. Nucl. Med. Technol. DO - 10.2967/jnmt.120.258020 SP - jnmt.120.258020 AU - Veronica Krull AU - Madison R. Kocher AU - William J Rieter Y1 - 2021/03/01 UR - http://tech.snmjournals.org/content/early/2021/03/12/jnmt.120.258020.abstract N2 - Altered biodistribution can be a source of diagnostic error in the interpretation of nuclear medicine studies. We report a case of increased liver and spleen uptake with 99mTc-dimercaptosuccinic acid (DMSA) believed to be a result of chlorhexidine-mediated colloid labeling. This finding underscores the principle that certain constituents of antiseptics may adversely affect the purity of radiopharmaceuticals during their preparation. ER -